Circulating tumor cells (CTCs) are malignant cells that have detached from primary or metastatic tumor sites and entered the peripheral bloodstream. As a critical component of liquid biopsy, the ...
Figure illustrating how circulating tumor cells (CTCs) evade immune defenses in the bloodstream by upregulating immune checkpoints, altering MHC class I expression, forming clusters, and interacting ...
Glioblastoma (GBM) is an aggressive brain tumor characterized by marked intra- and inter-tumoral heterogeneity and inevitable recurrence. Although extracranial metastasis is rare, circulating tumor ...
Menarini Silicon Biosystems, a pioneer of cell-based liquid biopsy technology, announced today the publication in Clinical Cancer Research[1] of the CTC biomarker analysis from the PACE trial, a ...
Dr. Debu Tripathy discusses recent research on the use of circulating tumor DNA in metastatic breast cancer care. Circulating tumor DNA, also referred to as ctDNA, are small pieces of DNA that are ...
Thoracic medical oncologists and early drug development specialists at Memorial Sloan Kettering Cancer Center (MSK) continue to investigate new ways to improve outcomes for this patient population.
The American Cancer Society estimates that more than 313,780 cases of prostate cancer will be diagnosed in the United States in 2025, resulting in approximately 35,770 deaths. Bone metastasis - a ...
Study finds that a high-fat diet boosts platelet activation and tumor cell homing—effects reversible with diet change or platelet depletion. Study: The Impact of a High -Fat Diet and Platelet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback